NCT07242248: A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

Sponsor: Janssen-Cilag Ltd.. Phase: . Conditions: Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn's Disease